Management of Helicobacter pylori infection in the pediatric age.
Antibiotic susceptibility
C(13) urea breath test
ESPGHAN/NASPGHAN guidelines
Endoscopy
Erradicación
Erradication
Gastroscopia
Guías ESPGHAN/NASPGHAN
H. pylori stool antigen test
Helicobacter pylori
Sensibilidad a antibióticos
Test de antígeno de H. pylori en heces
Test del aliento urea C(13)
Triple terapia
Triple therapy
Journal
Anales de pediatria
ISSN: 2341-2879
Titre abrégé: An Pediatr (Engl Ed)
Pays: Spain
ID NLM: 101765626
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
23
03
2021
accepted:
21
05
2021
pubmed:
14
10
2021
medline:
17
11
2021
entrez:
13
10
2021
Statut:
ppublish
Résumé
The management of Helicobacter pylori infection in children is a consistent problem in clinical practice. Over the years, many questions have been raised regarding symptoms associated with the infection, the diagnostic methods and type of treatment. What is most controversial is determining the criteria that enable us to initiate and carry out the study in children. In the last 10 years, pediatricians have followed the joint ESPGHAN/NASPGHAN guidelines published in 2011 and updated in 2017 in the management of H. pylori in children. This document aims to unify the study indication criteria as well as the diagnosis and treatment recommendations for H. pylori infection in children and adolescents, so they can be used in both Primary and Hospital care.
Identifiants
pubmed: 34642127
pii: S2341-2879(21)00155-1
doi: 10.1016/j.anpede.2021.05.004
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
383.e1-383.e9Informations de copyright
Copyright © 2021 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.